Skip to search formSkip to main contentSkip to account menu

NCX 4040

Known as: NCX-4040, NCX4040 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

AspirinNitro Compounds
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Reconsidering the Role of Cyclooxygenase Inhibition in the Chemotherapeutic Value of NO-Releasing Aspirins for Lung Cancer
Nitric oxide-releasing aspirins (NO-aspirins) are aspirin derivatives that are safer than the parent drug in the gastrointestinal… 
2019
2019
Abstract 2960: NCX4040, a nitric oxide (NO) donating form of aspirin as a potential treatment for prostate cancer
2012
2012
Quinone-induced activation of Keap1/Nrf2 signaling by aspirin prodrugs masquerading as nitric oxide.
The promising therapeutic potential of the NO-donating hybrid aspirin prodrugs (NO-ASA) includes induction of chemopreventive… 
2011
2011
New microtubule polymerization inhibitors comprising a nitrooxymethylphenyl group.
2010
2010
Degradation in Human α B-κ Inhibition of I Exerts Anti-Inflammatory Effects through NCX 4040 , a Nitric Oxide-Donating Aspirin ,
2008
2008
THE EFFECT OF NITRO-ASPIRINS (NCX4016 AND NCX4040) ON THE APOPTOSIS OF RAT NEUTROPHILS IN VIVO
Non-steroidal anti-inflammatory drugs (NSAID) are widely used as anti-inflammatory agents, but they have serious side effects. In… 
2006
2006
MP-08.23: The effects of NCX4040 on apoptosis in cultured prostate cells
2006
2006
Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines*
Although non steroidal antiinflammatory drugs (NSAIDs) have been shown to be effective as chemopreventive agents, important side… 
2004
2004
232 In vitro and in vivo antitumor efficacy of NCX-4040, a nitric oxide-releasing non-steroidal anti-inflammatory drug, in combination with antineoplastic drugs on human colon cancer lines
2004
2004
222 P53-mediated apoptosis induced by NCX 4040, a nitric oxide-releasing aspirin derivative, in human colon cancer cell lines
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)